AbbVie
The Director, Global Allergan Aesthetics Forecasting serves as the primary interface between the Pipeline Commercialization & Strategy team, Allergan Aesthetics Finance, and the Global Center of Excellence Forecasting team. This role is responsible for establishing and leading P&L modeling standards, designing planning processes, and driving the deployment of forecasting methodologies aligned with enterprise standards. The position focuses on harmonizing tools, supporting AI-enabled modeling, and fostering cross-functional partnerships to ensure accurate financial forecasting and strategic decision support.
Headquarters
North Chicago, Illinois, United States
Company Size
10001+ employees
Founded
2013
AbbVie is a global, research-driven biopharmaceutical company that was spun off from Abbott Laboratories in 2013. It develops and commercializes specialty medicines across immunology, oncology, neuroscience, eye care and virology — with Humira historically its flagship product — and has broadened its portfolio through acquisitions (notably Allergan) and strategic collaborations. AbbVie emphasizes a robust R&D pipeline, targeted therapies, and global commercial and manufacturing capabilities. The company focuses on delivering long-term treatment options for complex, chronic and serious diseases.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for AbbVie.
33% above the average for this role